HLA-DRB1*15:01-DQA1*01:02-DQB1*06:02 Haplotype Protects Autoantibody-Positive Relatives From Type 1 Diabetes Throughout the Stages of Disease Progression

Classification and Diagnosis of Diabetes

Fajans, S. S. (1990) · Medical Entomology and Zoology · Cited by 2,356 · see citing works

Overadjustment bias and unnecessary adjustment in epidemiologic studies.

Schisterman, E. F., Cole, S. R., & Platt, R. W. (2009) · Epidemiology · doi:10.1097/ede.0b013e3181a819a1 · Cited by 2,096 · cited 1× · see citing works

HLA-DQβ gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus

Todd, J. A., Bell, J. I., & McDevitt, H. O. (1987) · Nature · doi:10.1038/329599a0 · Cited by 2,046 · see citing works

(2) Classification and diagnosis of diabetes

American Diabetes Association (2015) · Diabetes Care · doi:10.2337/dc15-s005 · Cited by 1,841 · see citing works

Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children

Ziegler, A. G., Rewers, M., Simell, O., Simell, T., Lempainen, J., Steck, A., Winkler, C., Ilonen, J., Veijola, R., Knip, M., et al. (2013) · JAMA · doi:10.1001/jama.2013.6285 · Cited by 1,312 · see citing works

Staging presymptomatic type 1 diabetes: A scientific statement of JDRF, the Endocrine Society, and the American Diabetes Association

Insel, R. A., Dunne, J. L., Atkinson, M. A., Chiang, J. L., Dabelea, D., Gottlieb, P. A., Greenbaum, C. J., Herold, K. C., Krischer, J. P., Lernmark, Å., et al. (2015) · Diabetes Care · doi:10.2337/dc15-1419 · Cited by 1,216 · see citing works

The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes

Wenzlau, J. M., Juhl, K., Yu, L., Moua, O., Sarkar, S. A., Gottlieb, P., Rewers, M., Eisenbarth, G. S., Jensen, J., Davidson, H. W., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705894104 · Cited by 1,014 · see citing works

Aspartic acid at position 57 of the HLA-DQ beta chain protects against type I diabetes: a family study.

Morel, P. A., Dorman, J. S., Todd, J. A., McDevitt, H. O., & Trucco, M. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.21.8111 · Cited by 384 · see citing works

Genetics of Type 1 Diabetes

Noble, J. A., & Erlich, H. A. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a007732 · Cited by 335 · see citing works

Analysis of HLA-DQ Genotypes and Susceptibility in Insulin-Dependent Diabetes Mellitus

Baisch, J. M., Weeks, T., Giles, R. C., Hoover, M. L., Šťastný, P., & Capra, J. D. (1990) · New England Journal of Medicine · doi:10.1056/nejm199006283222602 · Cited by 332 · see citing works

Harmonization of glutamic acid decarboxylase and islet antigen-2 autoantibody assays for National Institute of Diabetes and Digestive and Kidney Diseases consortia

Bonifacio, E., Yu, L., Williams, A. K., Eisenbarth, G. S., Bingley, P. J., Marcovina, S. M., Adler, K., Ziegler, A. G., Mueller, P. W., Schatz, D. A., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0293 · Cited by 291 · see citing works

HLA-DQB1*0602 Is Associated With Dominant Protection From Diabetes Even Among Islet Cell Antibody–Positive First-Degree Relatives of Patients with IDDM

Pugliese, A., Gianani, R., Moromisato, R., Awdeh, Z., Alper, C. A., Erlich, H. A., Jackson, R. A., & Eisenbarth, G. S. (1995) · Diabetes · doi:10.2337/diab.44.6.608 · Cited by 207 · see citing works

The TrialNet Natural History Study of the Development of Type 1 Diabetes: objectives, design, and initial results

Mahon, J. L., Sosenko, J. M., Rafkin‐Mervis, L., Krause-Steinrauf, H. J., Lachin, J. M., Thompson, C. M., Bingley, P. J., Bonifacio, E. E., Palmer, J. P., Eisenbarth, G. S., et al. (2008) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2008.00464.x · Cited by 202 · see citing works

HLA associated genetic predisposition to autoimmune diseases: Genes involved and possible mechanisms

Thorsby, E., & Lie, B. A. (2005) · Transplant Immunology · doi:10.1016/j.trim.2005.03.021 · Cited by 197 · see citing works

A Mechanism for the Major Histocompatibility Complex–linked Resistance to Autoimmunity

Schmidt, D., Verdaguer, J., Averill, N., & Santamaría, P. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.7.1059 · Cited by 195 · see citing works

Determinant capture as a possible mechanism of protection afforded by major histocompatibility complex class II molecules in autoimmune disease.

Deng, H., Apple, R. J., Clare-Salzler, M. J., Trembleau, S., Mathis, D. J., Adorini, L., & Sercarz, E. E. (1993) · The Journal of Experimental Medicine · doi:10.1084/jem.178.5.1675 · Cited by 141 · see citing works

A Risk Score for Type 1 Diabetes Derived From Autoantibody-Positive Participants in the Diabetes Prevention Trial–Type 1

Sosenko, J. M., Krischer, J. P., Palmer, J. P., Mahon, J. L., Cowie, C. C., Greenbaum, C. J., Cuthbertson, D. D., Lachin, J. M., Skyler, J. S., & the Diabetes Prevention Trial–Type 1 Study Group (2008) · Diabetes Care · doi:10.2337/dc07-1459 · Cited by 105 · see citing works

Zinc transporter-8 autoantibodies improve prediction of type 1 diabetes in relatives positive for the standard biochemical autoantibodies

Yu, L., Boulware, D. C., Beam, C. A., Hutton, J. C., Wenzlau, J. M., Greenbaum, C. J., Bingley, P. J., Krischer, J. P., Sosenko, J. M., Skyler, J. S., et al. (2012) · Diabetes Care · doi:10.2337/dc11-2081 · Cited by 104 · see citing works

GAD65 Autoantibodies Detected by Electrochemiluminescence Assay Identify High Risk for Type 1 Diabetes

Miao, D., Guyer, K. M., Dong, F., Jiang, L., Steck, A. K., Rewers, M., Eisenbarth, G. S., & Yu, L. (2013) · Diabetes · doi:10.2337/db13-0534 · Cited by 97 · see citing works

Implication of Specific DQB1 Alleles in Genetic Susceptibility and Resistance by Identification of IDDM Siblings With Novel HLA-DQB1 Allele and Unusual DR2 and DR1 Haplotypes

Erlich, H. A., Griffith, R. L., Bugawan, T. L., Ziegler, R., Alper, C. A., & Eisenbarth, G. S. (1991) · Diabetes · doi:10.2337/diab.40.4.478 · Cited by 83 · see citing works

Cell-surface MHC density profiling reveals instability of autoimmunity-associated HLA

Miyadera, H., Ohashi, J., Lernmark, Å., Kitamura, T., & Tokunaga, K. (2014) · Journal of Clinical Investigation · doi:10.1172/jci74961 · Cited by 80 · see citing works

Proinsulin/Insulin Autoantibodies Measured With Electrochemiluminescent Assay Are the Earliest Indicator of Prediabetic Islet Autoimmunity

Yu, L., Dong, F., Miao, D., Fouts, A., Wenzlau, J. M., & Steck, A. K. (2013) · Diabetes Care · doi:10.2337/dc12-2245 · Cited by 78 · see citing works

A Peptide Binding Motif for HLA-DQA1*0102/DQB1*0602, the Class II MHC Molecule Associated with Dominant Protection in Insulin-Dependent Diabetes Mellitus

Ettinger, R. A., & Kwok, W. W. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.5.2365 · Cited by 77 · see citing works

Development of Autoantibodies in the TrialNet Natural History Study

Vehik, K., Beam, C. A., Mahon, J. L., Schatz, D., Haller, M. J., Sosenko, J. M., Skyler, J. S., Krischer, J. P., & for the TrialNet Natural History Study Group (2011) · Diabetes Care · doi:10.2337/dc11-0560 · Cited by 75 · see citing works

The multiple origins of Type 1 diabetes

Pugliese, A. (2012) · Diabetic Medicine · doi:10.1111/dme.12081 · Cited by 66 · see citing works

Electrochemiluminescence Assays for Insulin and Glutamic Acid Decarboxylase Autoantibodies Improve Prediction of Type 1 Diabetes Risk

Miao, D., Steck, A. K., Zhang, L., Guyer, K. M., Jiang, L., Armstrong, T., Muller, S. M., Krischer, J. P., Rewers, M., Yu, L., et al. (2015) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2014.0186 · Cited by 64 · see citing works

Major histocompatibility complex structure and function

Altmann, D. M., & Trowsdale, J. (1989) · Current Opinion in Immunology · doi:10.1016/0952-7915(89)90103-9 · Cited by 63 · see citing works

Trends of Earlier and Later Responses of C-peptide to Oral Glucose Challenges With Progression to Type 1 Diabetes in Diabetes Prevention Trial–Type 1 Participants

Sosenko, J. M., Palmer, J. P., Rafkin, L. E., Krischer, J. P., Cuthbertson, D., Greenbaum, C. J., Eisenbarth, G., Skyler, J. S., & Diabetes Prevention Trial–Type 1 Study Group (2010) · Diabetes Care · doi:10.2337/dc09-1770 · Cited by 62 · see citing works

T-Cell Responses to Islet Antigens Improves Detection of Autoimmune Diabetes and Identifies Patients With More Severe β-Cell Lesions in Phenotypic Type 2 Diabetes

Goel, A., Chiu, H. K., Felton, J. L., Palmer, J. P., & Brooks‐Worrell, B. (2007) · Diabetes · doi:10.2337/db06-0552 · Cited by 59 · see citing works

DR- and DQ-Associated Protection from Type 1A Diabetes: Comparison of DRB111401 and DQA110102-DQB1106021

REDONDO, M. J., Kawasaki, E., Mulgrew, C. L., Noble, J. A., Erlich, H. A., Freed, B. M., Lie, B. A., Thorsby, E., Eisenbarth, G. S., Undlien, D. E., et al. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.10.6920 · Cited by 50 · see citing works

Functional consequences of HLA-DQ8 homozygosity versus heterozygosity for islet autoimmunity in type 1 diabetes

Eerligh, P., van Lummel, M., Zaldumbide, A., Moustakas, A. K., Duinkerken, G., Bondinas, G. P., Koeleman, B. P. C., Papadopoulos, G. K., & Roep, B. O. (2011) · Genes and Immunity · doi:10.1038/gene.2011.24 · Cited by 49 · see citing works

Islet Cell Antibody-Positive Relatives with Human Leukocyte Antigen DQA110102, DQB110602: Identification by the Diabetes Prevention Trial-Type 11

Greenbaum, C. J., Schatz, D., Cuthbertson, D. D., Zeidler, A., Eisenbarth, G. S., & Krischer, J. P. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.3.6459 · Cited by 47 · see citing works

Detection of antibodies directed to the N-terminal region of GAD is dependent on assay format and contributes to differences in the specificity of GAD autoantibody assays for type 1 diabetes

Williams, A. J. K., Lampasona, V., Schlosser, M., Mueller, P. W., Pittman, D. L., Winter, W. E., Akolkar, B., Wyatt, R., Brigatti, C., Krause, S., et al. (2015) · Diabetes · doi:10.2337/db14-1693 · Cited by 46 · see citing works

Sequence Analysis of the Diabetes-Protective Human Leukocyte Antigen-DQB110602 Allele in Unaffected, Islet Cell Antibody-Positive First Degree Relatives and in Rare Patients with Type 1 Diabetes1

Pugliese, A., Kawasaki, E., Zeller, M., Yu, L., Babu, S. R., Solimena, M., Moraes, C. T., Pietropaolo, M., Friday, R. P., Trucco, M., et al. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.5.5684 · Cited by 39 · see citing works

Identification of peptides from autoantigens GAD65 and IA-2 that bind to HLA class II molecules predisposing to or protecting from type 1 diabetes.

Harfouch-Hammoud, E., Walk, T. B., Otto, H., Jung, G., Bach, J., Endert, P. V., & Caillat‐Zucman, S. (1999) · Diabetes · doi:10.2337/diabetes.48.10.1937 · Cited by 38 · see citing works

Specific Human Leukocyte Antigen DQ Influence on Expression of Antiislet Autoantibodies and Progression to Type 1 Diabetes

REDONDO, M. J., Babu, S. R., Zeidler, A., Orban, T., Yu, L., Greenbaum, C. J., Palmer, J. P., Cuthbertson, D. D., Eisenbarth, G. S., Krischer, J. P., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1695 · Cited by 37 · see citing works

Reactivity to N-Terminally Truncated GAD65(96–585) Identifies GAD Autoantibodies That Are More Closely Associated With Diabetes Progression in Relatives of Patients With Type 1 Diabetes

Williams, A. J. K., Lampasona, V., Wyatt, R. C., Brigatti, C., Gillespie, K. M., Bingley, P. J., & Achenbach, P. (2015) · Diabetes · doi:10.2337/db14-1694 · Cited by 33 · see citing works

Islet Cell Antibody-Positive Relatives with Human Leukocyte Antigen DQA10102, DQB10602: Identification by the Diabetes Prevention Trial-Type 1

Greenbaum, C. J. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.3.1255 · Cited by 33 · see citing works

A new HLA-DR2 extended haplotype is involved in insulin-dependent diabetes mellitus susceptibility

Carcassi, C., Trucco, G., Trucco, M., & Contu, L. (1991) · Human Immunology · doi:10.1016/0198-8859(91)90021-z · Cited by 31 · see citing works

Extensive study of DRB, DQA, and DQB gene polymorphism in 23 DR2-positive, insulin-dependent diabetes mellitus patients

Zeliszewski, D., Tiercy, J., Boîtard, C., Gu, X., Loche, M., Krishnamoorthy, R., Simonney, N., Élion, J., Bach, J., Mach, B., et al. (1992) · Human Immunology · doi:10.1016/0198-8859(92)90065-u · Cited by 26 · see citing works

D6S265*15 marks a DRB1*15, DQB1*0602 haplotype associated with attenuated protection from type 1 diabetes mellitus

Valdes, A. M., Thomson, G., Graham, J., Zarghami, M., McNeney, B., Kockum, I. S., Smith, A. G., Lathrop, M. G., Steenkiste, A. R., Dorman, J. S., et al. (2005) · Diabetologia · doi:10.1007/s00125-005-0011-8 · Cited by 26 · see citing works

Ethnic Differences in the Associations between the HLA‐DRB1*04 Subtypes and Type 1 Diabetes

Rewers, A. H., Babu, S. R., Wang, T. B., Bugawan, T. L., Barriga, K., Eisenbarth, G. S., & ERLICH, H. A. (2003) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1288.047 · Cited by 25 · see citing works

Promiscuous binding of proinsulin peptides to Type 1 diabetes-permissive and -protective HLA class II molecules

Astill, T. P., Ellis, R. J., Arif, S., Tree, T. I. M., & Peakman, M. (2003) · Diabetologia · doi:10.1007/s00125-003-1070-3 · Cited by 23 · see citing works

Molecular Modelling of HLA‐DQ Suggests a Mechanism of Resistance in Type 1 Diabetes

Hoover, M. L., & MARTA, R. T. (1997) · Scandinavian Journal of Immunology · doi:10.1046/j.1365-3083.1997.d01-389.x · Cited by 23 · see citing works

Mutational analysis of critical residues determining antigen presentation and activation of HLA-DQ0602 restricted T-cell clones

Reichstetter, S., Papadopoulos, G. K., Moustakas, A. K., Swanson, E., Liu, A. W., Beheray, S., Ettinger, R. A., Nepom, G. T., & Kwok, W. W. (2002) · Human Immunology · doi:10.1016/s0198-8859(01)00377-9 · Cited by 21 · see citing works

Limited Loss of Tolerance to Islet Autoantigens in ICA+ First Degree Relatives of Patients with Type I Diabetes Expressing the HLA DQB1*0602 Allele

Gianani, R., Verge, C. F., Moromisato, R., Yu, L., Zhang, Y. J., Pugliese, A., & Eisenbarth, G. S. (1996) · Journal of Autoimmunity · doi:10.1006/jaut.1996.0058 · Cited by 18 · see citing works

The Development and Utility of a Novel Scale That Quantifies the Glycemic Progression Toward Type 1 Diabetes Over 6 Months

Sosenko, J. M., Skyler, J. S., Beam, C. A., Boulware, D. C., Mahon, J. L., Krischer, J. P., Greenbaum, C. J., Rafkin, L. E., Matheson, D., Herold, K. C., et al. (2015) · Diabetes Care · doi:10.2337/dc14-2787 · Cited by 18 · see citing works

An Explanation for the Neutral Effect of DR2 on IDDM Susceptibility in Central Italy

Sorrentino, R., de Grazia, U., Buzzetti, R., Nisticò, L., Iannicola, C., Costanzi, S., & TOSI, R. M. (1992) · Diabetes · doi:10.2337/diab.41.8.904 · Cited by 15 · see citing works

Genetic protection from insulin-dependent diabetes mellitus

Pugliese, A. (1997) · Diabetes, Nutrition & Metabolism · Cited by 8 · see citing works

Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing

Alzheimer Disease Genetics Consortium (ADGC), Kunkle, B. W., The European Alzheimer’s Disease Initiative (EADI), Cohorts for Heart and Aging Research in Genomic Epidemiology Consortium (CHARGE), Genetic and Environmental Risk in AD/Defining Genetic, P. A. E. R. F. A. D. C. (., Grenier-Boley, B., Sims, R., Bis, J. C., Damotte, V., Naj, A. C., et al. (2019) · Nature Genetics · doi:10.1038/s41588-019-0358-2 · Cited by 2,946 · see citing works

Introducing the Endotype Concept to Address the Challenge of Disease Heterogeneity in Type 1 Diabetes

Battaglia, M., Ahmed, S., Anderson, M. S., Atkinson, M. A., Becker, D., Bingley, P. J., Bosi, E., Brusko, T. M., DiMeglio, L. A., Evans-Molina, C., et al. (2020) · Diabetes Care · doi:10.2337/dc19-0880 · Cited by 351 · see citing works

A Type 1 Diabetes Genetic Risk Score Predicts Progression of Islet Autoimmunity and Development of Type 1 Diabetes in Individuals at Risk

REDONDO, M. J., Geyer, S. M., Steck, A. K., Sharp, S. A., Wentworth, J. M., Weedon, M. N., Antinozzi, P. A., Sosenko, J. M., Atkinson, M. A., Pugliese, A., et al. (2018) · Diabetes Care · doi:10.2337/dc18-0087 · Cited by 176 · see citing works

Current understandings of the pathogenesis of type 1 diabetes: genetics to environment

Giwa, A. M., Ahmed, R., Omidian, Z., Majety, N., Karakus, K. E., Omer, S. M., Donner, T., & Hamad, A. R. A. (2020) · World Journal of Diabetes · doi:10.4239/wjd.v11.i1.13 · Cited by 137 · see citing works

The landscape of host genetic factors involved in immune response to common viral infections

Kachuri, L., Francis, S. S., Morrison, M. L., Wendt, G. A., Bossé, Y., Cavazos, T. B., Rashkin, S. R., Ziv, E., & Witte, J. S. (2020) · Genome Medicine · doi:10.1186/s13073-020-00790-x · Cited by 125 · see citing works

A Global Perspective of Latent Autoimmune Diabetes in Adults

Mishra, R., Hodge, K. M., Cousminer, D. L., Leslie, R. D., & Grant, S. F. A. (2018) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2018.07.001 · Cited by 87 · see citing works

Type 1 Diabetes TrialNet: A Multifaceted Approach to Bringing Disease-Modifying Therapy to Clinical Use in Type 1 Diabetes

Bingley, P. J., Wherrett, D. K., Shultz, A., Rafkin, L. E., Atkinson, M. A., & Greenbaum, C. J. (2018) · Diabetes Care · doi:10.2337/dc17-0806 · Cited by 84 · see citing works

The Genetic Architecture of Type 1 Diabetes

Jerram, S. T., & Leslie, R. D. (2017) · Genes · doi:10.3390/genes8080209 · Cited by 72 · see citing works

Disease-Modifying Therapies in Type 1 Diabetes: A Look into the Future of Diabetes Practice

Greenbaum, C. J., VanBuecken, D., & Lord, S. M. (2019) · Drugs · doi:10.1007/s40265-018-1035-y · Cited by 55 · see citing works

Using the T Cell Receptor as a Biomarker in Type 1 Diabetes

Nakayama, M., & Michels, A. W. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.777788 · Cited by 48 · see citing works

Strength in Numbers: Opportunities for Enhancing the Development of Effective Treatments for Type 1 Diabetes—The TrialNet Experience

Greenbaum, C. J., Speake, C., Krischer, J. P., Buckner, J. H., Gottlieb, P. A., Schatz, D., Herold, K. C., & Atkinson, M. A. (2018) · Diabetes · doi:10.2337/db18-0065 · Cited by 48 · see citing works

Fifty years of HLA-associated type 1 diabetes risk: history, current knowledge, and future directions

Noble, J. A. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1457213 · Cited by 42 · see citing works

Progression from islet autoimmunity to clinical type 1 diabetes is influenced by genetic factors: results from the prospective TEDDY study

Beyerlein, A., Bonifacio, E. E., Vehik, K., Hippich, M., Winkler, C., Frohnert, B. I., Steck, A. K., Hagopian, W., Krischer, J. P., Lernmark, Å., et al. (2018) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2018-105532 · Cited by 40 · see citing works

Index60 Identifies Individuals at Appreciable Risk for Stage 3 Among an Autoantibody-Positive Population With Normal 2-Hour Glucose Levels: Implications for Current Staging Criteria of Type 1 Diabetes

Nathan, B. M., REDONDO, M. J., Ismail, H. M., Jacobsen, L. M., Sims, E. K., Palmer, J. P., Skyler, J. S., Bocchino, L. E., Geyer, S. M., & Sosenko, J. M. (2021) · Diabetes Care · doi:10.2337/dc21-0944 · Cited by 36 · see citing works

Transcription Factor 7-Like 2 (TCF7L2) Gene Polymorphism and Progression From Single to Multiple Autoantibody Positivity in Individuals at Risk for Type 1 Diabetes

REDONDO, M. J., Steck, A. K., Sosenko, J. M., Anderson, M. S., Antinozzi, P. A., Michels, A. W., Wentworth, J. M., Atkinson, M. A., Pugliese, A., Geyer, S. M., et al. (2018) · Diabetes Care · doi:10.2337/dc18-0861 · Cited by 34 · see citing works

Failed Genetic Protection: Type 1 Diabetes in the Presence of HLA-DQB1*06:02

Simmons, K. M., Mitchell, A. M., Alkanani, A. K., McDaniel, K. A., Baschal, E. E., Armstrong, T., Pyle, L. L., Yu, L., & Michels, A. W. (2020) · Diabetes · doi:10.2337/db20-0038 · Cited by 26 · see citing works

The amino acid variants in HLA II molecules explain the major association with adult-onset Still's disease in the Han Chinese population

Teng, J., Chen, X., Chen, J., Zeng, T., He, L., Li, M., Luo, C., Liu, S., Ding, T., Yimaiti, K., et al. (2020) · Journal of Autoimmunity · doi:10.1016/j.jaut.2020.102562 · Cited by 20 · see citing works

Oral Insulin Delay of Stage 3 Type 1 Diabetes Revisited in <i>HLA DR4-DQ8</i> Participants in the TrialNet Oral Insulin Prevention Trial (TN07)

Zhao, L. P., Papadopoulos, G. K., Skyler, J. S., Parikh, H. M., Kwok, W. W., Bondinas, G. P., Moustakas, A. K., Wang, R., Pyo, C.-W., Nelson, W. C., et al. (2024) · Diabetes Care · doi:10.2337/dc24-0573 · Cited by 20 · see citing works

Isogenic Cellular Systems Model the Impact of Genetic Risk Variants in the Pathogenesis of Type 1 Diabetes

Wallet, M. A., Santostefano, K. E., Terada, N., & Brusko, T. M. (2017) · Frontiers in Endocrinology · doi:10.3389/fendo.2017.00276 · Cited by 20 · see citing works

Regulatory SVA retrotransposons and classical HLA genotyped-transcripts associated with Parkinson’s disease

Kulski, J. K., Suzuki, S., Shiina, T., Pfaff, A. L., & Kõks, S. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1349030 · Cited by 18 · see citing works

Cross-ancestral GWAS identifies 29 variants across head and neck cancer subsites

Ebrahimi, E., Sangphukieo, A., Park, H. A., Gaborieau, V., Ferreiro-Iglesias, A., Diergaarde, B. B., Ahrens, W., Alemany, L., Arantes, L. M., Betka, J., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-63842-z · Cited by 17 · see citing works

Diverse human leukocyte antigen association of type 1 diabetes in north India

Kumar, N., Mehra, N. K., Kanga, U., Kaur, G., Tandon, N., Chuzho, N., Mishra, G., & Neolia, S. C. (2019) · Journal of Diabetes · doi:10.1111/1753-0407.12898 · Cited by 17 · see citing works

Clinical characteristics and HLA associations of azithromycin‐induced liver injury

Conlon, C., Li, Y., Ahmad, J., Barnhart, H. X., Fontana, R. J., Ghabril, M., Hayashi, P. H., Kleiner, D. E., Lee, W. M., Navarro, V., et al. (2024) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.18160 · Cited by 16 · see citing works

Multiple sclerosis is accompanied by lack of KIR2DS1 gene: A meta-analysis

Shahsavar, F., Mapar, S., & Ahmadi, S. A. Y. (2016) · Genomics Data · doi:10.1016/j.gdata.2016.09.009 · Cited by 16 · see citing works

Type 1 Diabetes: Disease Stratification

Insel, R. A., Dutta, S., & Hedrick, J. A. (2017) · Biomedicine Hub · doi:10.1159/000481131 · Cited by 15 · see citing works

Classical HLA alleles are associated with prevalent and persistent cervical high-risk HPV infection in African women

Adebamowo, S. N., & Adeyemo, A. (2019) · Human Immunology · doi:10.1016/j.humimm.2019.04.011 · Cited by 15 · see citing works

Self-Antigens Targeted by Regulatory T Cells in Type 1 Diabetes

Mitchell, A. M., & Michels, A. W. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23063155 · Cited by 14 · see citing works

Time to reframe the disease staging system for type 1 diabetes

Jacobsen, L. M., Atkinson, M. A., Sosenko, J. M., & Gitelman, S. E. (2024) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(24)00239-0 · Cited by 13 · see citing works

Admixture as a source for HLA variation in Neolithic European farming communities

da Silva, N. A., Özer, O., Haller-Caskie, M., Chen, Y.-R., Kolbe, D., Schade-Lindig, S., Wahl, J., Berszin, C., Francken, M., Görner, I., et al. (2025) · Genome biology · doi:10.1186/s13059-025-03509-6 · Cited by 13 · see citing works

Biology and Natural History of Type 1 Diabetes Mellitus

Fernandes, T. A. A. D. M., de Azevedo, J. C. V., Cavalcante, G. A., de Medeiros, I. A. C. M., Lanza, D. C. F., de Araújo, J. M. G., Bezerra, F. L., & Fernandes, J. V. (2022) · Current Pediatric Reviews · doi:10.2174/1573396318666220409001955 · Cited by 13 · see citing works

Adult‐onset type 1 diabetic patients with less severe clinical manifestation have less risk DR‐DQ genotypes than childhood‐onset patients

Ren, W., Yang, D., Jiang, Z., Xian, Y., Huang, Q., Luo, S., Zheng, X., Yan, J., Xu, W., Yao, B., et al. (2020) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3357 · Cited by 13 · see citing works

Yeast display platform with expression of linear peptide epitopes for high-throughput assessment of peptide-MHC-II binding

Huisman, B. D., Balivada, P. A., & Birnbaum, M. E. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.102913 · Cited by 12 · see citing works

The Antidiabetic Activity of Wild-Growing and Cultivated Medicinal Plants Used in Romania for Diabetes Mellitus Management: A Phytochemical and Pharmacological Review

Trașcă, D.-M., Dop, D., Stoica, G. A., Niculescu, Ș. A., Carmen, N. E., Văruț, R. M., & Singer, C. E. (2025) · Pharmaceuticals · doi:10.3390/ph18071035 · Cited by 12 · see citing works

The origin of autoimmune diseases: is there a role for ancestral HLA-II haplotypes in immune hyperactivity

Ruiz-Pablos, M., Paiva, B., & Zabaleta, A. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1710571 · Cited by 11 · see citing works

The Clinical Course of Patients with Preschool Manifestation of Type 1 Diabetes Is Independent of the HLA DR-DQ Genotype

Reinauer, C., Rosenbauer, J., Bächle, C., Herder, C., Roden, M., Ellard, S., Franco, E. D., Karges, B., Holl, R. W., Enczmann, J., et al. (2017) · Genes · doi:10.3390/genes8050146 · Cited by 11 · see citing works

Association of HLA-DQ Heterodimer Residues −18β and β57 With Progression From Islet Autoimmunity to Diabetes in the Diabetes Prevention Trial–Type 1

Zhao, L. P., Skyler, J. S., Papadopoulos, G. K., Pugliese, A., Najera, J. A., Bondinas, G. P., Moustakas, A. K., Wang, R., Pyo, C., Nelson, W. C., et al. (2022) · Diabetes Care · doi:10.2337/dc21-1628 · Cited by 10 · see citing works

HNF1B-MODY Masquerading as Type 1 Diabetes: A Pitfall in the Etiological Diagnosis of Diabetes

Francis, Y., Tiercelin, C., Alexandre‐Heymann, L., Larger, É., & Dubois‐Laforgue, D. (2022) · Journal of the Endocrine Society · doi:10.1210/jendso/bvac087 · Cited by 10 · see citing works

Nucleic acid biomarkers of β cell stress and death in type 1 diabetes

Syed, F., & Evans‐Molina, C. (2016) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000261 · Cited by 10 · see citing works

Associations of CTLA4 +49 A/G Dimorphism and HLA-DRB1*/DQB1* Alleles With Type 1 Diabetes from South India

Ravi, P. M., Chinniah, R., Sivanadham, R., Murali, V., Panneerselvam, D., Pushkala, S., & Balakrishnan, K. (2018) · Biochemical Genetics · doi:10.1007/s10528-018-9856-7 · Cited by 10 · see citing works

Natural Selection Signatures in the Hondo and Ryukyu Japanese Subpopulations

Liu, X., Matsunami, M., Horikoshi, M., Ito, S., Ishikawa, Y., Suzuki, K., Momozawa, Y., Niida, S., Kimura, R., Ozaki, K., et al. (2023) · Molecular Biology and Evolution · doi:10.1093/molbev/msad231 · Cited by 8 · see citing works

Association of Alleles of Human Leukocyte Antigen Class II Genes and Severity of COVID-19 in Patients of the ‘Red Zone’ of the Endocrinology Research Center, Moscow, Russia

Troshina, E. A., Yukina, M. Y., Nuralieva, N. F., Vasilyev, E., Rebrova, O. Y., Ахматова, Р. Р., Ikonnikova, A. Y., Savvateeva, E. N., Gryadunov, D. A., Mel'nichenko, G. A., et al. (2022) · Diseases · doi:10.3390/diseases10040099 · Cited by 7 · see citing works

Rationally designed small molecules to prevent type 1 diabetes

Ostrov, D. A., Gottlieb, P. A., & Michels, A. W. (2019) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000470 · Cited by 7 · see citing works

Transcriptomic profiling and machine learning uncover gene signatures of psoriasis endotypes and disease severity

Rider, A., Grantham, H. J., Smith, G. R., Watson, D., Casement, J., Cockell, S., Gisby, J., Foulkes, A., Henkin, R., Iqbal, W. A., et al. (2026) · Communications Medicine · doi:10.1038/s43856-025-01325-4 · Cited by 5 · see citing works

Mechanistic Insights into Immune-Microbiota Interactions and Preventive Role of Probiotics Against Autoimmune Diabetes Mellitus

Devi, M. B., Sarma, H. K., Mukherjee, A. K., & Khan, M. R. (2023) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-023-10087-1 · Cited by 5 · see citing works

Enterovirus Neutralizing Antibodies, Monocyte Toll Like Receptors Expression and Interleukin Profiles Are Similar Between Non-affected and Affected Siblings From Long-Term Discordant Type 1 Diabetes Multiplex-Sib Families: The Importance of HLA Background

Bergamin, C. S., Hurtado, E. C. P., Oliveira, L. M. D. S., Gabbay, M. A. L., Piveta, V. M., Bittencourt, C., Russo, D. H., Carmona, R., Sato, M. N., & Dib, S. A. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.555685 · Cited by 4 · see citing works

A case of latent autoimmune diabetes in the young positive for zinc transporter 8 antibody with type 2 diabetes characteristics

Matsuda, T., Osaki, Y., Soma, N., Azuma, T., Ezura, A., Mitani, Y., Kikuchi, Y., Matsumoto, N., Murayama, Y., Sugano, Y., et al. (2025) · Clinical Pediatric Endocrinology · doi:10.1297/cpe.2024-0083 · Cited by 3 · see citing works

Shed light on molecular immunogenetic pathophysiology of type 1 diabetes to improve advanced treatment strategies

Moosavi, A., Tabrizi, Z. A., Eghbali, Z., Barzegari, A., Hejazian, S. M., Kheiri, S., & Seyedmadani, S. (2025) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2025.112359 · Cited by 2 · see citing works

Diagnosis of Type 1 Diabetes

Joseph, K., Waikar, A. R., Siebel, S., & Patel, A. (2021) · Contemporary Endocrinology · doi:10.1007/978-3-030-64133-7_3 · Cited by 2 · see citing works

Association between HLA alleles and sub-phenotype of childhood steroid-sensitive nephrotic syndrome

Lee, H., Wang, L., Ni, F.-F., Yang, X., Feng, S.-P., Gao, X., Chi, H., Luo, Y., Chen, X., Yang, B., et al. (2022) · World Journal of Pediatrics · doi:10.1007/s12519-021-00489-y · Cited by 2 · see citing works

Pathogenesis of Type 1 Diabetes

Pugliese, A. (2018) · Endocrinology · doi:10.1007/978-3-319-45015-5_7 · Cited by 2 · see citing works

Autoimmune Endocrine Disorders

Barker, J. M. (2018) · Springer eBooks · doi:10.1007/978-3-319-73782-9_34 · Cited by 2 · see citing works

Faculty Opinions recommendation of Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing.

Yan, R. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.735170868.793558625 · Cited by 2 · see citing works

The analysis of a subset of HLA region associations in type 1 diabetes and multiple sclerosis suggests the involvement mechanisms other than antigen presentation in the pathogenesis

Singh, S. K. (2021) · Informatics in Medicine Unlocked · doi:10.1016/j.imu.2021.100831 · Cited by 1 · see citing works

Characteristics of Type 1 Diabetes Among Patients Carrying the Protective HLA ‐ DQB1 *06:02 Allele

Taka, A., Härkönen, T., Vähäsalo, P., Vatanen, T., Lempainen, J., Veijola, R., Turtinen, M., Ilonen, J., Knip, M., & Register, T. F. P. D. (2024) · HLA · doi:10.1111/tan.15720 · Cited by 1 · see citing works

Pathogenesis of Type 1 Diabetes

Pugliese, A. (2018) · Endocrinology · doi:10.1007/978-3-319-27317-4_7-1 · Cited by 1 · see citing works

The Search for Immunological Biomarkers in Type 1 Diabetes Mellitus (T1DM) and Multiple Sclerosis (MS): Th40 Cells Provide a Common Autoimmune Link

Wagner, D. H. (2022) · Biomarkers in disease · doi:10.1007/978-3-031-08014-2_29 · Cited by 1 · see citing works

Autoimmune Endocrine Disorders

Barker, J. M. (2024) · Springer eBooks · doi:10.1007/978-3-031-66296-6_35 · Cited by 1 · see citing works

Aspects of the Pre-Diabetic Period in Type 1 Diabetes

Åkerman, L. (2016) · Linköping University medical dissertations · doi:10.3384/disss.diva-132171

Human leukocyte antigen-DQA1*0501 allele and its association with pathogenesis of type 1 diabetes mellitus among Iraqi children

Al-Tu'ma, A. F., Jeddoa, Z. M. A., El-Yassin, H. D., & Al-Koofee, D. A. F. (2019) · Gene Reports · doi:10.1016/j.genrep.2019.100517

Neuroendocrine and Biobehavioral Influences on Diabetes in Youth

COMMISSARIAT, P. V., McGill, D. E., & Laffel, L. M. (2020) · Springer eBooks · doi:10.1007/978-3-030-33286-0_3

The role of CXCL9 and IFIH1 in insulin dependent diabetes mellitus

Huchem, Z. I., & Ghali, K. H. (2020) · AIP conference proceedings · doi:10.1063/5.0027463

Papel da via de sinalização Wnt canônica na proliferação e função secretora da célula beta pancreática em condições in vitro e na pré-diabetes

Maschio, D. A. (2018) · doi:10.47749/t/unicamp.2018.1102624

The Search for Immunological Biomarkers in Type 1 Diabetes Mellitus (T1DM) and Multiple Sclerosis (MS): Th40 Cells Provide a Common Autoimmune Link

Wagner, D. H. (2022) · Biomarkers in disease · doi:10.1007/978-3-030-81303-1_29-1

Genetic risk markers of type 1 diabetes within the HLA complex in children of the Volga region

Георгиевна, К. К., Bezlepkina, O. B., Sharonov, G. V., Shabalkina, A. V., Сальнікова, М. А., Шагина, И. А., Da, C., Strongin, L. G., & Загайнов, В. Е. (2026) · FOCUS Endocrinology · doi:10.62751/2713-0177-2026-7-1-01

Genetics of Type 1 Diabetes

Onengut-Gumuscu, S., & REDONDO, M. J. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-11985-9.00014-7

Mitochondrial and protein homeostasis pathways are transcriptionally impaired in islets during type 1 diabetes pathogenesisPreprint

Cuaycal, A. E., Butterworth, E. A., Stimpson, S. E., Chen, J., Lenchik, N. I., Baratta, L. A., Phelps, E. A., Grieshaber, S. S., Atkinson, M. A., Qian, W., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.07.29.741469

Genetics of Celiac Disease in Southern Brazil: High‐Resolution HLA Haplotypes and Non‐ HLA Polymorphisms

da Silva, F. V., Bumiller‐Bini, V., Auer, E. D., dos Santos, P. I., Cline, N., Oliveira, L. C., Hundt, J. E., Wittig, M., Franke, A., Norman, P. J., et al. (2026) · HLA · doi:10.1111/tan.70972

The role of three-locus HLA haplotypes (HLA-DRB1-DQA1-DQB1) in pathogenesis of alloimmunization, atopy, and viral Infection

Butina, E., Suetina, I. G., & Lyubeznova, O. N. (2026) · Medical Immunology (Russia) · doi:10.15789/1563-0625-tro-3307

DR15-DQ6 remains dominantly protective against type 1 diabetes throughout the first five decades of life

Thomas, N., Dennis, J., Sharp, S. A., Kaur, A., Misra, S., Walkey, H., Johnston, D., Oliver, N., Hagopian, W., Weedon, M., et al. (2021) · Diabetologia · doi:10.1007/s00125-021-05513-4 · Cited by 17 · see citing works

Failed Genetic Protection: Type 1 Diabetes in the Presence of HLA-DQB1*06:02

Simmons, K. M., Mitchell, A. M., Alkanani, A. K., McDaniel, K. A., Baschal, E. E., Armstrong, T., Pyle, L. L., Yu, L., & Michels, A. W. (2020) · Diabetes · doi:10.2337/db20-0038 · Cited by 26 · see citing works

252-OR: Failed Genetic Protection: Type 1 Diabetes in the Presence of HLA-DQB1*06:02

Simmons, K. M., Mitchell, A. M., Alkanani, A. K., McDaniel, K. A., Baschal, E. E., Armstrong, T., Pyle, L., Yu, L., & Michels, A. W. (2020) · Diabetes · doi:10.2337/db20-252-or

Specific Human Leukocyte Antigen DQ Influence on Expression of Antiislet Autoantibodies and Progression to Type 1 Diabetes

REDONDO, M. J., Babu, S. R., Zeidler, A., Orban, T., Yu, L., Greenbaum, C. J., Palmer, J. P., Cuthbertson, D. D., Eisenbarth, G. S., Krischer, J. P., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1695 · Cited by 37 · see citing works

D6S265*15 marks a DRB1*15, DQB1*0602 haplotype associated with attenuated protection from type 1 diabetes mellitus

Valdes, A. M., Thomson, G., Graham, J., Zarghami, M., McNeney, B., Kockum, I. S., Smith, A. G., Lathrop, M. G., Steenkiste, A. R., Dorman, J. S., et al. (2005) · Diabetologia · doi:10.1007/s00125-005-0011-8 · Cited by 26 · see citing works